Montana Mastery of Medical Cannabis Certification

Adult-use cannabis sales began in Montana earlier this year in counties where voters approved I-190, the 2020 ballot measure that legalized cannabis in Montana. Through local referenda, counties that voted against the measure are able to opt in and allow cannabis businesses in their jurisdiction if local voters approve. About half the state’s counties currently allow cannabis sales.

Last year lawmakers passed House Bill 701, a bill that made modifications to the voter-approved ballot initiative. A provision included in that law also makes it possible for localities to opt out of allowing cannabis sales, making the future of cannabis dispensaries in some municipalities uncertain. Anti-cannabis activists are hoping to shut down cannabis businesses in some counties later this year.

In the background of these local debates, Montana’s Department of Revenue reports that legal cannabis sales generated $20 million in new tax revenue in the first half of 2022, and sales increased over 20% from January to June.

Source: MPP

Qualifying Conditions

• Admittance into hospice care in accordance with rules adopted by the department
• Cachexia or wasting syndrome
• Cancer
• Central nervous system disorder resulting in chronic, painful spasticity or muscle spasms
• Crohn’s disease
• Epilepsy or an intractable seizure disorder
• Glaucoma
• HIV/AIDS
• Intractable nausea or vomiting
• Painful peripheral neuropathy
• Post traumatic stress disorder
• Severe chronic pain that is persistent pain of severe intensity that significantly interferes with daily activities as documented by the patient’s treating physician

• U.S. Controlled Substances Act
• Drug Schedule – Cannabis Schedule I
• Drug Schedule (Graphic)
• COVID Cannabis Guidelines
• Economic Impact
• Cannabis genus of flowering plants in the family Cannabaceae
• Legal differentiation between hemp and marijuana distinguished by their respective concentrations of the cannabinoid delta-9 tetrahydrocannabinol (THC)
• 2018 Farm Bill
  • Impact on hemp classification
• SAFE Banking Act
• U.S. Pat. No. 6,630,507
• Trademarks
• Ogden Memo
• Cole Memo
• Wilkenson Memo
• 2018 Sessions Memorandum
• Rohrabacher–Blumenauer Amendment
• Joyce Amendment
• Conant v. Walters
•  What Medical Professionals Can Legally Provide To Their Patients (Graphic)
• Cannabis and Cannabis-Derived Compounds: Quality Considerations for Clinical Research
• Guidance for Industry – Downloadable PDf
• Cannabis and Cannabis-Derived Compounds: Quality Considerations for Clinical Research
• Guidance for Industry – Video Explainer
• Taxes
• Affirmative Defense
• Bankruptcy Protection
• Employment Law
• Access to Banking  – Financial Crimes Enforcement Network FinCEN Guidance
• Copyright and Registration

• Origins of Cannabis
• Early History of Cannabis Cultivation
  • Silk Route
  • Indica
  • Sativa
  • Ruderalis
  • Hybrids
• Medical Cannabis Through The Ages – How Cannabis Spanned The Globe – Downloadable Graphic
• Medical Cannabis In Ancient China
• Medical Cannabis In Other Ancient Civilizations
• Cannabis Timeline – Downloadable Graphic
• Power Struggles Over Cannabis
• Cannabis In Europe and The West
• U.S. Prohibition
  • Marihuana Tax Act
  • Prohibition
  • “Reefer Madness”
• The Implications of U.S. Prohibition
• Shafer Commission
• National Institute on Drug Abuse
• The Legacy Cannabis Marketplace
• Cannabis Cultivation Culture Booms
• The Beginning of the End of Prohibition
  • Prop 215 – Compassionate Care Act
  • I-502
  • Amendment 64
• U.S. Cannabis Policy Today
• Legal Cannabis Lexicon
• Hemp vs. Cannabis
• ASTM – D37 Committee

• Introduction of the Endocannabinoid System (ECS)
• Largest Receptor System
• ECS – Vaideo Explainer
• Newly Discovered
• Chemical Bridge to All Bodily Functions
• Homeostasis
• Healthy Body = Healthy ECS
• ECS – Downloadable Graphic
• Dr Jake Felice – What is the Endocannabinoid System (ECS)? Video Interview
• Largest Neurotransmitter System of all “the body’s supercomputer”
• 1964 discovery of THC and CBD – Raphael Mechoulam, Ph.D and Yehiel Gaoni, Ph.D
• The Scientist – video regarding Raphael Mechoulam, Ph.D discoveries
• Allyn Howlett, Ph.D  – Isolating THC in the brain – 1998
  • No cannabinoid receptors in the cardiac and respiratory centers of the brainstem therefore no overdose from cannabis
• Raphael Mechoulam, Ph.D found in 1992, brain chemical that mirrors the effects of THC
  • Two brain chemicals – anandamide, Sanskrit word “ananda” brain chemical that mimics THC and CBD, 2-Arachidonoylglycerol, which they named 2-AG.
• Endogenous Molecules “endocannabinoids”.
• CB1 receptors, and CB2 receptors
• Cannabinoids and how they attach to receptors
• CB1 receptors
  • Located in the central nervous system and affect many brain functions including movement, anxiety, stress, fear, pain, appetite, reward, and motor control
• CB2 receptors
  • CB2 receptors control the release of cytokines, immuno-regulatory proteins, that are linked to inflammation during illness or after injury.
• Retrograde Inhibition
• Lack of education on the Endocannabinoid System
• Clinical Studies
• At a Glance – Downloadable Infographic
• Homeostatsis
• Humand Thriving Behavior and the ECS

• Minor Cannabinoids: CBG CBC CBN THCV
• Cannabinoid Guide – Downloadable Graphic
• Terpenes
• Terpene Chart – Downloadable Graphic
• What Are Terpenes? – Video
• The Entourage Effect
• Taming THC: potential cannabis synergy and phytocannabinoid-terpenoid entourage effects- Downloadable PDF
• Cannabis and Cannabis Extracts: Greater Than the Sum of Their Parts? – Downloadable PDF
• Tolerance and ECS Down Regulation
• Botanical vs. Single Molecule Compounds & Cannabinoids and Opioids

• Inhalation: Smoking vs. Vaporization
• In the News Discussions
• Cannabis Flower vs. Concentrate
• Different Concentrate Consistencies
• Extraction Methods
• Winterization
• Concentrates Using Solvents
• Solventless Concentrates
• Edibles, Oral Mucosal, Topicals and Suppositories
• The Role of the Medical Provider
• The Role of the Dispensary: Experts within the Dispensary

• Considerations Before Medicating with Cannabis
• Set and Setting
• Drug-Drug Interactions
• Relative Contraindications
• Youth Under 25
• Patients and Cardiac Conditions
• Patients with Psychiatric Diagnoses
• Immunocompromised Patents
• Biphasic Effect
• Finding the Appropriate Dose
• Recommended Ratios for Specific Illnesses

• How Testing Works
• Contaminants: Pesticides, Fungi and Mold
• How to Interpret a Test

• Anxiety Disorders
• Cancer
• Epilepsy
• Gastrointestinal Disorders
• Glaucoma
• HIV/AIDS
• Migraine Headaches
• Multiple Sclerosis
• Neurodegenerative Disorders
• Neuropathy
• Pain
• Palliative Care
• Parkinson’s Disease
• Post Traumatic Stress Disorders
• Sleep Disorders
• Traumatic Brain Injury (TBI)
• Endometriosis
• Premenstrual Syndrome and Premenstrual Dysphoric Disorder
• Menopause

• Opioids
• Cannabis and Opioids
• Global Patterns of Opioid Use and Dependence
• Opioid-Related Overdose Deaths
• Pain Management
• Comparative Pain Scale
• Addictive Potential of Opioids
• Prescribing Opioids for Chronic Pain
• Underlying Principles – Downloadable Graphic
• Studies Show Cannabinoid Medications Effective in Reducing Opioid Use
• Cause of Death by Drug – Downloadable Graphic
• Drug Dependence
• Opioid Use Disorder
• Emerging Evidence for Cannabis’ Role in Opioid Use Disorder – Downloadable PDF
• Cannabis: A Promising Option for the Opioid Crisis – Downloadable PDF
• Cannabis and NSAIDS: More Good News

• Gateway Theory, Addiction and Brain Function
• Cannabis is Highly Addictive
• Cannabis Kills Brain Cells
• Cannabis Kills Motivation
• Cannabis Impairs Memory
• Cannabis Leads to Insanity
• Cannabis Causes Lung Cancer
• Most Recreational Users are Heavy Users
• Cannabis is Dangerous

• Cannabis Use Disorder (CUD)
• Short Term Side Effects
• Long Term Side Effects
• Physical Effects
  • Breathing Problems
  • Increased Heart Rate
  • Development
• Cannabinoid Hypermesis Syndrome (CHS)
• Mental Effects
• What to Avoid
• Cannabis and Driving
• Cannabis Over Consumption
• Cannabis Tolerance